Navigation Links
Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic
Date:7/15/2008

ATHENS, Ga., July 15 /PRNewswire/ -- Abeome Corporation, a Georgia-based biotech company, announced today a strategic equity investment by Cato BioVentures and a collaboration with Cato Research Ltd., its global contract research and development organization. The investment and collaboration will help support continued development of Abeome's lead ovarian cancer project.

Abeome's proprietary technology vastly improves the development of monoclonal antibodies and Abeome is deploying its technology to provide a shotgun approach to develop an array of antibodies for an ovarian cancer therapeutic target. The company has developed novel monoclonal antibodies to four ovarian cancer cell lines and has begun screening these antibodies in search of those which cause either cancer cell growth inhibition or death.

Joel Eisner, Ph.D., Associate Principal of Cato BioVentures, states, "We are fascinated with Abeome's ability to develop such a large library of monoclonal antibodies by use of their technology. They have pushed the bottleneck of therapeutic development to the screening step which will provide a broader selection of novel antibodies to more cancer targets."

Monoclonal antibodies have become the centerpiece of many high-profile therapeutic products. Their specificity to disease targets, like cancer, has drawn significant attention from the biotech community.

"Ovarian cancer is a dreadful disease which is frequently diagnosed at a very late stage of development. With no effective therapeutic drugs on the market to date, we expect to address this unmet medical need. Our technology improves the likelihood of finding that one-of-a-kind antibody that can make the difference," said Mike Wanner, President and CEO of Abeome. "We are excited to have Cato Research join our expanding team of professional experts to help us with this important project".

About Abeome

Abeome Corporation is a biotechnology company dedicated to leverag
'/>"/>

SOURCE Abeome Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
2. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
3. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
4. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis
7. Childrens Brain Tumor Foundations Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research
8. Small Business Innovation Research Program Awards Grant to Biomoda
9. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
10. New Research Just Released: Women Can Now Safely Postpone Motherhood Until Time Is Right
11. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...0 Radius Health ("Radius") announc...ion to its second institutional financing round, i...on and the total amount raised since the company,s...tional investors participated in the financing, le...PM Capital, The Wellcome Trust, HealthCare Venture...
(Date:11/20/2008)...ire-FirstCall/ -- PAREXEL International Corporatio...tical services provider, today announced that it h...atory consulting and clinical research capabilitie...ow has locations throughout five important biophar...clude Argentina, Brazil, Chile, and Mexico. This e...
(Date:11/19/2008)...PRNewswire/ -- Posit Science Corporation,research...for Neuroscience,Annual Conference in Washington,...may benefit Baby Boomers. The computerized brain ...adaptive exercises that target auditory and,langu...generalized,improvements in cognition by improvin...
(Date:11/19/2008)...t achieve statistical significance , , ISEL...os Corporation (Nasdaq: PARS ) today announced r...ical NanoEmulsion (NE) drug delivery technology fo..., The multi-center, randomized, double-blinded,... efficacy of the Company,s 3% Diclofenac Diethanol...
Breaking Medicine Technology:Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2New Questions Raised About Lung Cancer Screening 26945 1New Questions Raised About Lung Cancer Screening 26945 2New Questions Raised About Lung Cancer Screening 26945 3SCAN Health Plan Arizona Announces Its 2009 MAPD Benefits for Maricopa County 26942 1SCAN Health Plan Arizona Announces Its 2009 MAPD Benefits for Maricopa County 26942 2Small Animal Imaging Market 3A Biospace Lab Wins Frost 26 Sullivan Accolade for Its Successful Product Line Strategy 8030 1Small Animal Imaging Market 3A Biospace Lab Wins Frost 26 Sullivan Accolade for Its Successful Product Line Strategy 8030 2Small Animal Imaging Market 3A Biospace Lab Wins Frost 26 Sullivan Accolade for Its Successful Product Line Strategy 8030 3Small Animal Imaging Market 3A Biospace Lab Wins Frost 26 Sullivan Accolade for Its Successful Product Line Strategy 8030 4Acupressure calms children before surgery 26939 1Acupressure calms children before surgery 26939 2
...ation for Cancer Research,annual meeting -, PRINCE...-,Medarex, Inc. today presented preclinical data d...separate studies exploring the,efficacy and safety...ody-drug conjugates. CD19 and CD70 are both attrac...ch to cancer therapy. They are,expressed on cancer...
...e/ -- Researchers from the,Barbara Ann Karmanos Ca...dence today that an antibiotic typically prescribe...ventually treating,certain types of cancers. , Q. ...manos, and,members of his lab announced the findin... (CQ) appears to have an anti-tumor effect,in mice...
Other Medicine Technology:Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 2Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 3Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 4Alzheimer's Drug Shows Promise in Fighting Cancer 2
(Date:11/21/2008)...xperiments in mice find running increases producti... 21 (HealthDay News) -- In experiments in mice, ex...ction of brain stem cells usually seen with aging,...e restoration of the brain,s ability to stave off ...estore a neurochemical that is essential for the p...
(Date:11/21/2008)...ALLAS, Nov. 21 In a statewide surv...Texas Institute for Surgery at Presbyterian Hospit...s 2008 annual listing of " Super Doctors ." , ...work with Key Professional Media, Inc. to survey m...tate of Texas to ask, "If you needed medical care,...
(Date:11/21/2008)...EW ROCHELLE, N.Y., Nov. 21 A prest...lthcare providers will gather in Williamsburg, VA ...learn practical, clinical information on cutting-e...ures, and innovative research advances that impact...ation, and registration information is available a...
(Date:11/21/2008)...OSTON, Nov. 21 Innerscope Research...rm specializing in Emotional Response Measurement,...ves who will strengthen the,company,s research an...itiatives. , The three appointments, who de...Geoffrey Gill as Chief Financial Officer and Vice ...
Breaking Medicine News(10 mins):Health News:Exercise Keeps the Brain Young 2Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2
...ing them reason to attempt suicide, according to a...on at Auckland University and its results have bee... Health. It revealed that 34 per cent of young peo...t about killing themselves while 13 per cent had a...
...t synacthen, which when injected simulates the bod...id. This is// most common in sports where sports c...ncing tool. Synacthen and injecting performance en...r than medical treatment is banned. Though some ...
...rtheastern state of Meghalaya is encouraging mothe...ing its population to two// million, its chieftain...l (KHADC), a constitutional body to protect and pr... culture, is worried that the state's Khasi and th...
... November 15 and will continue till December 31, d...t program was started in 2006 for senior citizens ... reduce prescription drug costs. The benefits of ... 2007 during which time citizens who enrolled for ...
Other Medicine News:Health News:Sports Cheats Beware - New Test To Detect Synacthen Found 2Health News:Cash Rewards for Meghalaya Tribes to Encourage Baby Boom 2
The 15 and 18 Sony Flat Screen Monitors with articulating arm can be used in conjunction with existing surgical monitors or as replacements.
Colour video monitors.
The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty.
Camera and light source in one compact "Plug-and-Play" device.
Medicine Products: